Award Timing Disclosure	12 Months Ended
Dec. 31, 2024
Award Timing Disclosures [Line Items]
Award Timing MNPI Disclosure	Timing of Stock Option and other Equity Award Grants: Although the Company does not have a formal policy regarding the timing of awards of stock options, stock appreciation rights (“SARs”) and/or similar option-like instruments grants to the Company’s named executive officers, the Company does not make these awards or any other form of equity compensation in anticipation of the release of material, non-public information. Similarly, the Company does not time the release of material, non-public information based on stock-option, SARs or other equity award grant dates for the purpose of affecting the value of any award to the Company’s named executive officers. As the Company’s common stock is not traded on any national securities exchange, the Board and Compensation Committee set the exercise price of options based upon a valuation of the Company’s shares conducted by an independent third party for the purpose of valuing shares of the Company’s common stock. In fiscal year 2024, none of the Company’s named executive officers were granted any options to purchase shares of the Company’s common stock, SARs or similar option-like instruments.
Award Timing Method	Although the Company does not have a formal policy regarding the timing of awards of stock options, stock appreciation rights (“SARs”) and/or similar option-like instruments grants to the Company’s named executive officers, the Company does not make these awards or any other form of equity compensation in anticipation of the release of material, non-public information.
Award Timing Predetermined	false
Award Timing MNPI Considered	true
Award Timing, How MNPI Considered	Although the Company does not have a formal policy regarding the timing of awards of stock options, stock appreciation rights (“SARs”) and/or similar option-like instruments grants to the Company’s named executive officers, the Company does not make these awards or any other form of equity compensation in anticipation of the release of material, non-public information. Similarly, the Company does not time the release of material, non-public information based on stock-option, SARs or other equity award grant dates for the purpose of affecting the value of any award to the Company’s named executive officers.
MNPI Disclosure Timed for Compensation Value	false

Timing of Stock Option and other Equity Award Grants:

Although the Company does not have a formal policy regarding the timing of awards of stock options, stock appreciation rights (“SARs”) and/or similar option-like instruments grants to the Company’s named executive officers, the Company does not make these awards or any other form of equity compensation in anticipation of the release of material, non-public information. Similarly, the Company does not time the release of material, non-public information based on stock-option, SARs or other equity award grant dates for the purpose of affecting the value of any award to the Company’s named executive officers. As the Company’s common stock is not traded on any national securities exchange, the Board and Compensation Committee set the exercise price of options based upon a valuation of the Company’s shares conducted by an independent third party for the purpose of valuing shares of the Company’s common stock. In fiscal year 2024, none of the Company’s named executive officers were granted any options to purchase shares of the Company’s common stock, SARs or similar option-like instruments.

false

Award Timing, How MNPI Considered

Although the Company does not have a formal policy regarding the timing of awards of stock options, stock appreciation rights (“SARs”) and/or similar option-like instruments grants to the Company’s named executive officers, the Company does not make these awards or any other form of equity compensation in anticipation of the release of material, non-public information. Similarly, the Company does not time the release of material, non-public information based on stock-option, SARs or other equity award grant dates for the purpose of affecting the value of any award to the Company’s named executive officers.